The issue that regulators will address is the reproducibility of your method. You use the word 'probe' as I would use the words 'test result'.
You should demonstrate that when you do multiple probes of one sample preparation your results are within a defined limit. For example, if you prepared a solution of dissolved drug that was known to contain 1000 ppm of methanol and you tested this single solution three times the RSD of your test results should be within say.... 10%.
This demonstrates that your method has a suitable reproducibility. Now if you were to prepare three different solutions of an untested drug sample and you performed a single test (probe) on each of the three solutions and got results with a mean of 2000 ppm that gave a RSD less than 10% you would have a high confidence level that the measured level is accurate and that your sample is homogeneous.
But if your results from the three probes had a mean of 2000 ppm but the RSD of the results was 30% then you would conclude that your sample was not homogeneous or your method of sample preparation was not reproducible.
Going back to the beginning, if, when you tested a single solution three times and got results with a RSD of 30%, then your method itself is not reproducible.
You have to show your test method is reproducible, your preparation of a probe solution is reproducible, and the bulk sample is homogeneous for any meaningful results to be valid.
best wishes,
Rodney George
consultant